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ardiac Power Is the Strongest Hemodynamic
orrelate of Mortality in Cardiogenic Shock:
Report From the SHOCK Trial Registry
upert Fincke, MD,* Judith S. Hochman, MD, FACC,† April M. Lowe, MS,‡
enu Menon, MD, FACC,§ James N. Slater, MD, FACC,† John G. Webb, MD, FACC,
hierry H. LeJemtel, MD, FACC,¶ Gad Cotter, MD, FACC,# for the SHOCK Investigators
ew York and Bronx, New York; Watertown, Massachusetts; Chapel Hill and Durham, North Carolina;
nd Vancouver, Canada
OBJECTIVES We sought to analyze clinical, angiographic, and outcome correlates of hemodynamic
parameters in cardiogenic shock.
BACKGROUND The significance of right heart catheterization in critically ill patients is controversial, despite
the prognostic importance of the derived measurements. Cardiac power is a novel hemody-
namic parameter.
METHODS A total of 541 patients with cardiogenic shock who were enrolled in the SHould we
emergently revascularize Occluded Coronaries for cardiogenic shocK (SHOCK) trial registry
were included. Cardiac power output (CPO) (W) was calculated as mean arterial pressure 
cardiac output/451.
RESULTS On univariate analysis, CPO, cardiac power index (CPI), cardiac output, cardiac index, stroke
volume, left ventricular work, left ventricular work index, stroke work, mean arterial pressure,
systolic and diastolic blood pressure (all p  0.001), coronary perfusion pressure (p  0.002),
ejection fraction (p  0.013), and pulmonary artery systolic pressure (p  0.047) were
associated with in-hospital mortality. In separate multivariate analyses, CPO (odds ratio per
0.20 W: 0.60 [95% confidence interval, 0.44 to 0.83], p  0.002; n  181) and CPI (odds
ratio per 0.10 W/m2: 0.65 [95% confidence interval, 0.48 to 0.87], p  0.004; n  178)
remained the strongest independent hemodynamic correlates of in-hospital mortality after
adjusting for age and history of hypertension. There was an inverse correlation between CPI
and age (correlation coefficient: 0.334, p  0.001). Women had a lower CPI than men
(0.29  0.11 vs. 0.35  0.15 W/m2, p  0.005). After adjusting for age, female gender
remained associated with CPI (p  0.032).
CONCLUSIONS Cardiac power is the strongest independent hemodynamic correlate of in-hospital mortality
in patients with cardiogenic shock. Increasing age and female gender are independently
associated with lower cardiac power. (J Am Coll Cardiol 2004;44:340–8) © 2004 by the
American College of Cardiology Foundationc
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ahe usefulness of hemodynamic measurements with right
eart catheterization (RHC) in critically ill patients has
een questioned (1,2). Echocardiography has largely obvi-
ted the role of RHC as a diagnostic tool for the etiology of
ardiogenic shock (3–5), and the echocardiographic assess-
ent of cardiac function is of prognostic importance (6,7).
lthough studies examining the utility of RHC and mea-
urement of pulmonary capillary wedge pressure (PCWP)
nd cardiac output (CO) did not demonstrate significant
eneficial effects on patient outcome (1,8,9), PCWP and
O had independent prognostic value in 995 patients in
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Manuscript received December 11, 2003; revised manuscript received March 8,h004, accepted March 16, 2004.ardiogenic shock in the Global Utilization of Streptokinase
nd Tissue Plasminogen Activator for Occluded Coronary
rteries-I (GUSTO-I) trial (10).
The “SHould we emergently revascularize Occluded Cor-
naries for cardiogenic shocK” (SHOCK) trial was a ran-
omized trial of a strategy of early revascularization for
ardiogenic shock complicating an acute myocardial infarc-
ion (MI) (11). The results of the randomized trial have
een reported (12). Patients who were ineligible for the
andomized trial or who were trial-eligible but not randomized
ere prospectively enrolled in the SHOCK trial registry.
The purpose of the present study was to evaluate clinical,
ngiographic, and outcome correlates of hemodynamic param-
ters of patients with suspected cardiogenic shock secondary to
eft ventricular (LV) dysfunction after an acute MI.
In addition to analyzing traditional hemodynamic vari-
bles including blood pressure, PCWP, cardiac index (CI),
nd systemic vascular resistance (SVR), we evaluated a novel
emodynamic measure: cardiac power. Using the physical
r
t
i
c
c
C
s
p
c
o
c
M
S
r
b
r
o
p
A
p
e
P
d
d
i
i
f
c
c
D
s
o
i
t
r
m
c
c
P
f
L
b
(
c
d
R
u
t
s
r
w
(
t
R
t
a
p
r
a
i
3
p
a
a
c
t
r
d
(
z
a
[
d
s
F
(
w
(
341JACC Vol. 44, No. 2, 2004 Fincke et al.
July 21, 2004:340–8 Cardiac Power in Cardiogenic Shockule of fluids (power  pressure  flow), cardiac power is
he product of simultaneously measured cardiac output (or
ndex) and mean arterial blood pressure. Therefore, by
oupling both pressure and flow domains of the cardiovas-
ular system, it is a measure of cardiac pumping (13).
ardiac power can be determined without RHC noninva-
ively using various devices (14). In recent studies, cardiac
ower was shown to be instrumental in the diagnosis of
ardiogenic shock (15) and an important determinant of
utcome in patients with cardiogenic shock (16) and
hronic heart failure (17).
ETHODS
tudy design and data collection. The design of the
andomized SHOCK trial and SHOCK trial registry has
een published (11,18). Enrollment in the SHOCK trial
egistry required only that cardiogenic shock was suspected
n clinical grounds; RHC was not mandated. Patients were
rospectively registered at 36 international sites between
pril 1993 and August 1997. Data were collected from
atient charts by centrally trained study coordinators who
ntered the data onto standardized study report forms.
atient characteristics, MI characteristics, hemodynamic
ata, medications, procedures used, and vital status at
ischarge were recorded. The coronary angiograms obtained
n the SHOCK trial registry were analyzed by the local site
nvestigators. Data from cardiac catheterization reports
rom all sites were abstracted at the SHOCK trial clinical
oordinating center where standardized report forms were
ompleted.
efinitions. Predominant LV failure was indicated by the
ite investigators as the etiology of cardiogenic shock if none
f the following shock categories was thought to be present:
solated right ventricular shock, acute severe mitral regurgi-
ation, ventricular septal rupture, cardiac tamponade or
upture, prior severe valvular heart disease, dilated cardio-
yopathy, excess beta or calcium channel blockade, and
ardiogenic shock associated with recent hemorrhage or
Abbreviations and Acronyms
CI  cardiac index
CO  cardiac output
CPI  cardiac power index
CPO  cardiac power output
GUSTO-I  Global Utilization of Streptokinase and
Tissue Plasminogen Activator for Occluded
Coronary Arteries-I
IABP  intra-aortic balloon pump
LV  left ventricle/ventricular
MI  myocardial infarction
PCWP  pulmonary capillary wedge pressure
RHC  right heart catheter
SHOCK  SHould we emergently revascularize
Occluded Coronaries for cardiogenic shocK
SVR  systemic vascular resistanceardiac catheterization laboratory complication. (atient population and hemodynamic measurements. The
ollowing report is based on 541 patients with predominant
V failure whose hemodynamic measurements were made
etween 6 h before and up to 12 h after shock diagnosis
Fig. 1). Measurements of LV ejection fraction were in-
luded if they were obtained one day before, on the same
ay as, or one day after shock diagnosis.
Of the 541 patients analyzed, 406 (75%) underwent
HC (Fig. 1). Compared with patients who did not
ndergo RHC, those with RHC were younger; less likely
o have had a prior MI or renal insufficiency; had higher
ystolic blood pressure and diastolic blood pressure, heart
ate, and peak CPK; and were more frequently treated
ith dobutamine and an intra-aortic balloon pump
IABP) (Table 1).
The following measures were available on only one-half
o approximately two-thirds of the patients undergoing
HC due to an expansion of the case report forms during
he study period: CO, mean right atrial pressure, pulmonary
rtery systolic pressure, and pulmonary artery diastolic
ressure. In addition, right ventricular systolic pressure and
ight ventricular diastolic pressure were optional and only
vailable on just over one-fifth of RHC patients. Cardiac
ndex was recorded in 282 patients and PCWP recorded in
78. Left ventricular ejection fraction was measured in 196
atients (in 52% by echocardiography, in 47% by LV
ngiography, and in 0.5% by gated blood pool scan).
An estimate of coronary perfusion pressure was calculated
s diastolic blood pressure  PCWP. Nine patients with a
oronary perfusion pressure0 mm Hg were excluded from
his analysis (n  329). Their coronary perfusion pressure
esults are likely due to nonsimultaneous measurements of
iastolic blood pressure and PCWP or technical problems
underestimation of diastolic blood pressure with arm cuff,
ero position for RHC at bedside).
Cardiac power output (CPO) (W) was calculated as mean
rterial pressure CO/451, where mean arterial pressure
(systolic blood pressure  diastolic blood pressure)/3] 
iastolic blood pressure. Systemic vascular resistance (dyne
/cm5) was determined by the following equation: 80 
igure 1. Time of hemodynamic measurements and right heart catheter
RHC) status of patients with left ventricular (LV) failure in the SHould
e emergently revascularize Occluded Coronaries for cardiogenic shocK
SHOCK) registry.mean arterial pressure right atrial pressure)/CO. Cardiac
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Cardiac Power in Cardiogenic Shock July 21, 2004:340–8ower index (CPI) (W/m2) and systemic vascular resistance
ndex (dyne s/cm5/m2) were computed by substituting CO
ith CI in the respective formulas. One patient with a
egative value for SVR was excluded from any analyses
oncerning SVR and SVR index. Stroke work (g-m) was
alculated as (mean arterial pressure PCWP) 0.0136
troke volume. Stroke work index (g-m/m2) was determined
y stroke work/body surface area. Left ventricular work was
efined as (mean arterial pressure  PCWP)  CO 
.0136 (kg-m/min). Left ventricular work index was calcu-
ated as (mean arterial pressure  PCWP)  CI  0.0136
kg-m/min  m2). Hemodynamic measurements included
hose recorded while the patients were receiving supportive
herapy (sympathomimetic amines, 95%; and/or dobut-
mine, 60%; and/or IABP, 59%). If a patient had no IABP
r if the RHC measurements were obtained before insertion
f the IABP or after removal of the IABP, then RHC data
ere considered off IABP (73%). Right heart catheter
easurements made in the time interval between IABP
nsertion and removal were considered on IABP support
27%).
tatistical methods. Descriptive statistics are presented as
ean  SD for continuous data (or median and quartiles
or skewed data) and percentages for categorical data. A p
alue of 0.05 was considered as statistically significant.
isher’s exact test was used to compare all group
roportions.
Associations of continuous variables with patient charac-
eristic subgroups such as right heart catheterization, gen-
er, history of hypertension, prior MI, history of congestive
eart failure, diabetes, and renal insufficiency were examined
sing Student’s t test for normally distributed variables
heart rate) and the Wilcoxon rank-sum test for non-
ormally distributed variables.
Hemodynamic parameters by culprit artery and number
able 1. Baseline Demographic and Clinical Characteristics of Pa
verall and by Right Heart Catheterization
Characteristics All Patients
ge (yrs) 67.8  12.4 (541)
ale (%) 65.3 (541)
rior MI (%) 38.0 (518)
ypertension (%) 50.6 (514)
iabetes (%) 33.4 (527)
ongestive heart failure (%) 18.4 (512)
enal insufficiency (%) 10.1 (504)
ystolic BP (mm Hg)* 89.2  22.2 (525)
iastolic BP (mm Hg)* 54.3  14.8 (460)
eart rate (beats/min)* 96.5  26.0 (520)
edian peak total CPK (U/l) [Q1, Q3] 2,240 [825, 4,551] (509)
I to shock 6 h (%) 42.8 (493)
ransfer (%) 42.7 (541)
ympathomimetic amines (%) 95.3 (429)
obutamine (%) 59.7 (429)
ntraaortic balloon pump (%) 58.6 (541)
Measurements were obtained while on inotropic, sympathomimetic amine, and/or int
ercentile.
BP  blood pressure; CPK  creatine phosphokinase; MI  myocardial infarctif diseased vessels were analyzed using analysis of variance So compare normally distributed variables (heart rate and
ulmonary artery diastolic pressure) and the Kruskal-Wallis
est to compare non-normally distributed variables. For
ignificant overall effects, pairwise comparisons used the
onferroni method of adjustment to determine significance.
Logistic regression analysis was used to examine the
elationship between in-hospital mortality and hemody-
amic parameters and to display predicted mortality as a
unction of CPO. Units for odds ratios from logistic
egression were determined using a rule of approximately
0% of the SD with rounding to the next appropriate unit.
Using logistic regression and linear regression, patient
haracteristic and hemodynamic correlates of CPO or CPI
nd in-hospital mortality were assessed. In the subset of
atients with CPO data, logistic regression was performed
o determine correlates of both CPI and in-hospital mor-
ality. Those variables that remained significant at the 0.20
evel when modeled with CPI were entered into a multi-
ariate model. Single variables were removed in a stepwise
ethod until a model meeting a 0.05 significance level in all
ariables was attained. These steps were repeated with
PO.
In addition, receiver operator characteristic analysis was
erformed to determine a cutpoint for CPO that provides
n approximately equivalent sensitivity and specificity for
redicting in-hospital mortality.
Linear regression, with log-transformation of CI to
chieve normality, was used to study the relationship be-
ween CI, CPI, SVR, SVR index, including age, gender,
nd hemodynamics.
Spearman correlation coefficients were used to estimate
nivariate associations between CI, CPI, or SVR, and age.
Analyses were conducted using the Statistical Analysis
ystem (SAS, version 8.2., Cary, North Carolina) and
s With Shock Due to Predominant Left Ventricular Failure
RHC No RHC p Value
66.7  12.3 (406) 70.8  12.2 (135) 0.001
63.8 (406) 69.6 (135) 0.251
35.0 (394) 47.6 (124) 0.015
51.7 (393) 47.1 (121) 0.407
32.4 (398) 36.4 (129) 0.452
16.8 (392) 23.3 (120) 0.138
8.1 (385) 16.8 (119) 0.009
92.8  20.7 (391) 78.5  23.0 (134) 0.001
55.8  14.0 (361) 48.8  16.5 (99) 0.001
98.9  24.9 (390) 89.3  27.7 (130) 0.001
2,584 [1,118, 5,060] (386) 1,047 [263, 2,840] (123) 0.001
42.3 (371) 44.3 (122) 0.752
43.8 (406) 39.3 (135) 0.368
94.9 (294) 96.3 (135) 0.628
69.7 (294) 37.8 (135) 0.001
66.3 (406) 35.6 (135) 0.001
c balloon pump support. ( ) number of patients with available data; [ ] 25th–75th
C  right heart catheter.tient
raaorti-Plus 6 (Insightful Corp., Seattle, Washington) software.
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July 21, 2004:340–8 Cardiac Power in Cardiogenic ShockESULTS
emodynamic correlates of in-hospital mortality. The
verall mortality of the examined population (n  541) was
6.8%. The mortality of the subset of patients with CPO
ata (n  189) was significantly lower than those without
PO data (n  352) (42.9% vs. 64.2%, p  0.001).
On univariate analysis, a number of hemodynamic vari-
bles were correlated with in-hospital mortality (Table 2).
ultivariate logistic regression models were used to assess
he strength of CPI (n  178) and CPO (n  181) as
orrelates of in-hospital mortality after adjusting for patient
haracteristics and/or other hemodynamic parameters re-
ated to both in-hospital mortality and CPI or CPO.
ardiac power index (p  0.004) and CPO (p  0.002)
emained independently associated with in-hospital mortal-
ty after adjusting for the only remaining significant covari-
tes, age and history of hypertension (Tables 3 and 4). In
ddition, after adjusting for age and hypertension, LV work
ndex (n  171) with an odds ratio (95% confidence
nterval) per 0.4 kg-m/min  m2 increase of 0.75 (0.60,
able 2. Univariate Logistic Regression Results of Hemodynamic
Parameters* n Mean  S
ardiac power output 189 0.62  0
ardiac power index 253 0.33  0
ardiac output 204 3.86  1
troke volume 196 40.8  1
eft ventricular work index 244 1.36  0
eft ventricular work 182 2.61  1
troke work 180 27.2  1
troke work index 154 14.8  9
ardiac index 282 2.07  0
eft ventricular ejection fraction 196 30.0  1
ystolic blood pressure 525 89.2  2
ean arterial pressure 460 66.7  1
oronary perfusion pressure 329 33.4  1
iastolic blood pressure 460 54.3  1
ight ventricular diastolic pressure 88 14.4  7
eart rate 520 96.5  2
ight atrial pressure 204 13.9  6
CWP 378 24.0  8
ulmonary artery diastolic pressure 260 23.7  7
ulmonary artery systolic pressure 259 40.3  1
VR index 144 2,266 [1,782,
VR 143 1,257 [938, 1
ight ventricular systolic pressure 93 43.7  15
Measurements were obtained while on inotropic, sympathomimetic amine, and/or in
ercentile.
CI  confidence interval; PCWP  pulmonary capillary wedge pressure; SVR 
able 3. Multivariate Logistic Regression Results for In-Hospital
ortality (Using Cardiac Power Index) (n  178)
Variables
Odds Ratio
(95% Confidence Interval)
p
Value
ardiac power index 0.65 (0.48, 0.87)* 0.004
ge 1.78 (1.31, 2.42)* 0.001
istory of hypertension 0.46 (0.22, 0.94) 0.033
The odds ratio and confidence interval for cardiac power index is per 0.10 W/m2ncrease. The odds ratio and confidence interval for age is per 10-year increase. i.93), p 0.009, and LV work (n 174) with an odds ratio
95% confidence interval) per 0.7 kg-m/min increase of 0.75
0.60, 0.92), p  0.006, also remained independent, but
eaker, correlates of in-hospital mortality. Cardiac power
ndex, CPO, LV work index, and LV work continued to be
ignificant correlates of mortality after controlling for IABP
se. Predicted in-hospital mortality as a function of CPO
ith pointwise 95% confidence bands is displayed in Figure
. The odds ratio for mortality without adjustment for
aseline characteristics is 0.55 for each 0.20-W increase in
PO, that is, there is a 45% decrease in the odds of death.
utoff value for CPO to determine in-hospital mortali-
y. Because CPO was the strongest independent hemody-
amic correlate of outcome in the present cohort, we have
ttempted to determine a cutoff value for CPO that is most
ccurately related to outcome. By receiver operator charac-
eristic analysis, assuming an approximately equal sensitivity
nd specificity of 0.66, a CPO of 0.53 W was found to most
ccurately predict in-hospital mortality (c-statistic  0.69).
he probability of in-hospital mortality with a CPO 0.53
ameters for In-Hospital Mortality
Unit for
Odds Ratio
Odds Ratio
(95% CI) p Value
0.20 0.55 (0.41, 0.73) 0.001
0.10 0.61 (0.49, 0.77) 0.001
1 0.62 (0.49, 0.78) 0.001
10 0.69 (0.56, 0.84) 0.001
0.4 0.69 (0.58, 0.82) 0.001
0.7 0.70 (0.58, 0.84) 0.001
8 0.71 (0.59, 0.86) 0.001
5 0.72 (0.58, 0.91) 0.005
0.5 0.73 (0.62, 0.87) 0.001
7 0.81 (0.69, 0.96) 0.013
10 0.84 (0.77, 0.92) 0.001
8 0.84 (0.76, 0.93) 0.001
7 0.84 (0.75, 0.94) 0.002
7 0.85 (0.78, 0.94) 0.001
4 0.98 (0.78, 1.24) 0.877
10 1.00 (0.93, 1.07) 0.923
3 1.01 (0.89, 1.15) 0.862
5 1.09 (0.97, 1.22) 0.159
4 1.10 (0.96, 1.26) 0.164
6 1.14 (1.00, 1.29) 0.047
]† 600 1.14 (0.93, 1.39) 0.203
400 1.16 (0.93, 1.44) 0.186
8 1.17 (0.94, 1.46) 0.161
rtic balloon pump support. †Median given for SVR and SVR index. [ ]  25th–75th
mic vascular resistance.
able 4. Multivariate Logistic Regression Results for In-Hospital
ortality (Using Cardiac Power Output) (n  181)
Variables
Odds Ratio
(95% Confidence Interval)
p
Value
ardiac power output 0.60 (0.44, 0.83)* 0.002
ge 1.75 (1.29, 2.38)* 0.001
istory of hypertension 0.46 (0.23, 0.94) 0.033
The odds ratio and confidence interval for cardiac power output is per 0.20 WPar
D†
.30
.14
.60
8.5
.74
.54
6.5
.1
.79
2.8
2.2
5.9
4.4
4.8
.5
6.0
.6
.7
.4
1.8
2,860
,620]†
.8
tra-aoncrease. The odds ratio and confidence interval for age is per 10-year increase.
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Cardiac Power in Cardiogenic Shock July 21, 2004:340–8was 58% (positive predictive value), whereas the proba-
ility of survival given a CPO 0.53 W was 71% (negative
redictive value).
emodynamics in relation to baseline characteristics. We
ound a significant inverse correlation between CPI and age
correlation coefficient, 0.334, p  0.001), whereas age
nd SVR were positively correlated (0.347, p  0.001).
Women had a significantly lower CPI and CI than men
0.29  0.11 vs. 0.35  0.15 W/m2, p  0.005 and 1.82 
.57 vs. 2.22  0.87 l/min/m2, p  0.001) and a higher
edian SVR (1,456 [interquartile range, 1,248, 2,016] vs.
,095 [801, 1,360] dyne s/cm5, p  0.001). Although
omen were significantly older than men (70.7  11.6 vs.
6.2  12.6 years, p  0.001), after adjusting for age,
emale gender remained associated with CPI (p  0.032),
I (p  0.002), and SVR (p  0.001). In the subset of
atients with SVR data (n  142), support with epineph-
ine (42.9% vs. 26.7%, p  0.067) and norepinephrine
30.4% vs. 18.6%, p  0.154) tended to be used more
requently in women compared with men, although not
tatistically significant. Dopamine use was similar in women
nd men (87.5% vs. 86.1%, p  1.000). After adjusting for
pinephrine and norepinephrine use, female gender re-
ained a significant correlate of SVR (both, p  0.001).
lso, in the subset of patients with SVR data (n  143),
tilization of IABP support was comparable for women and
en (59.7% vs. 62.8%, p  0.728).
A total of 51% of patients had a history of hypertension,
hile 38% of patients had a prior MI, and 18% had
ongestive heart failure. A history of hypertension was
ssociated with lower CPI (0.31  0.15 vs. 0.35  0.13
/m2, p  0.001), whereas a prior MI (0.32  0.14 vs.
.33  0.14 W/m2, p  0.880) and a history of congestive
2
Figure 2. Unadjusted estimated in-hospital mortality by cardieart failure (0.30  0.10 vs. 0.33  0.15 W/m , p  c.596) were not. None of these conditions were associated
ith SVR. In contrast, mean PCWP was similar for
atients with and without a history of hypertension (23.9 
.8 vs. 24.4  8.8 mm Hg, p  0.768), whereas patients
ith a prior MI (25.9  9.0 vs. 23.2  8.5 mm Hg, p 
.003) and with a history of congestive heart failure (26.8 
1.3 vs. 23.5  8.1 mm Hg, p  0.016) had significantly
igher PCWP than patients without either such a history.
Diabetics comprised 33% of all patients, and 10% of all
atients had renal insufficiency. Diabetics and nondiabetics
ad comparable hemodynamics (including CPI), except for
edian SVR, diastolic blood pressure, and coronary perfu-
ion pressure, which were significantly lower in the diabetic
atients (SVR 1,064 [844, 1,410] vs. 1,298 [1,037, 1,782]
yne s/cm5, p 0.024; diastolic blood pressure 52.1 14.2
s. 55.5  15.1 mm Hg, p  0.004 and coronary perfusion
ressure 30.5  13.5 vs. 34.8  14.6 mm Hg, p  0.010).
emodynamic measures in patients with and without prior
enal insufficiency were similar.
emodynamic measurements, culprit artery, and extent
f coronary disease. Patients with left main artery related
I had higher pulmonary artery systolic pressures than
atients with right coronary artery related MI (53.4  12.5
s. 37.3  10.8 mm Hg, p  0.032) and higher PCWP
han patients with left anterior descending related MI (33.5
11.2 vs. 23.4 9.4 mm Hg, p 0.017) or right coronary
rtery related MI (33.5  11.2 vs. 23.2  7.7 mm Hg, p 
.011) (Table 5). The coronary perfusion pressure in pa-
ients with left main MI was lower than for all other culprit
rteries (26.0  21.9 vs. 34.5  13.9 mm Hg, p  0.054).
Standard hemodynamic parameters including SVR, SVR
ndex, and CPI were unrelated to the number of diseased
essels, whereas coronary perfusion pressure was signifi-
wer output (n  189) with pointwise 95% confidence bands.antly lower in patients with three-vessel disease compared
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airwise comparison (31.5  14.5 vs. 36.2  12.6 mm Hg,
 0.049 or vs. 37.7  15.4 mm Hg, p  0.029).
ISCUSSION
imitations of traditional hemodynamic measures. He-
odynamic monitoring has been used extensively during
he last decades for risk stratification and guiding treatment
f patients with cardiovascular destabilization, especially
cute heart failure and cardiogenic shock. However, in
ecent years, RHC has been complemented by echocardio-
raphic evaluation in the risk stratification of these patients
19). The echocardiographic measurement of LV ejection
raction and the severity of mitral regurgitation are strongly
orrelated with the outcome of patients in cardiogenic shock
20).
Although RHC-derived hemodynamic measurements
ike PCWP and CO are correlated with outcome (10),
HC use, per se, is not associated with any benefit (1,2) and
as raised concerns about harm (1,2,8). This observation is
ikely responsible for the diminishing use of RHC in
atients with hemodynamic instability (21), despite the lack
f sufficiently powered randomized trials (22).
There are various possible explanations for this apparent
aradox. Some of the current treatments applied to patients
ith acute heart failure and cardiogenic shock were shown
o improve symptoms, but not final outcome. Hence, the
itration of medications to achieve a set of predetermined
emodynamic goals might be actually detrimental to the
atient (23–25). Moreover, it is possible that the hemody-
amic measures and their presumed target values used in
treatment protocols” (26) are misleading. Primarily, CI and
CWP are currently used for hemodynamic monitoring.
owever, CI is not an index of cardiac contractility, but
ather a measure of cardiovascular flow and, therefore,
ffected by contractility, vascular stiffness, and resistance, as
ell as intravascular volume and ventricular filling pressures.
ulmonary capillary wedge pressure is a measure of intra-
ardiac pressure, reflecting ventricular compliance and vol-
me status, but not directly representing cardiac perfor-
able 5. Selected Hemodynamic Parameters of Patients With Sh
Left Anterior
Descending Artery
Left Ci
Ar
eart rate (beats/min) 103.2  22.6 (122) 106.5 
ight atrial pressure (mm Hg) 13.5  5.8 (53) 16.5 
AS (mm Hg) 38.9  11.7 (77) 41.0 
AD (mm Hg) 23.7  8.0 (76) 24.5 
CWP (mm Hg) 23.4  9.4 (106) 26.3 
ardiac index (l/min/m2) 2.11  0.69 (74) 2.42 
PI (W/m2) 0.33  0.13 (71) 0.37 
VEF (%) 26.5  9.6 (55) 30.0 
edian SVR (dyne s/cm5) 1,121 [838, 1,366] (40) 1,165 [978
easurements were obtained while on inotropic, sympathomimetic amine, and/or int
5th–75th percentile.
CPI  cardiac power index; LVEF  left ventricular ejection fraction; PAD 
ulmonary capillary wedge pressure; SVR  systemic vascular resistance.ance or pumping ability. Therefore, although theseeasures are correlated with patient outcome in some
tudies, they might be only secondarily related to more
undamental hemodynamic effectors.
ardiac power. In attempting to characterize a system
omposed of an energy source and pipes conducting this
nergy, the usual parameters used for characterizing the
ystem are the power of the energy generator and the
esistance of the conducting pipes. In the cardiovascular
ystem, the pumping power of the heart can be determined
y cardiac power, which is the product of simultaneously
easured CO (cardiovascular flow) and mean arterial (in-
ravascular) pressure.
Tan et al. (16) has shown that the resting CPO for a
emodynamically stable average sized adult is approximately
W. However, during stress or exercise, cardiac power
eserve can be recruited to increase the heart’s pumping
bility up to 6 W. In patients with chronic heart failure, this
ecruitable reserve is significantly diminished and is strongly
orrelated with outcome (17,27).
In acute heart failure, on the other hand, the patient
ecomes hemodynamically unstable, and most of the cardiac
umping potential is recruited in order to sustain life.
ence, cardiac power measurements in patients with acute
eart failure at rest represent most of the recruitable reserve
vailable during the acute event, and their measurement
eflects the severity of the patient’s condition.
In a recent study (15), we evaluated hemodynamic vari-
bles in patients with acute hemodynamic decompensation
ue to a variety of causes. We observed that CI, PCWP, and
lood pressure were not instrumental in determining the
atient’s exact diagnosis. It could be determined, however,
ith an accuracy of 95% by combining individual measures
f cardiac power and SVR. Moreover, studies attempting to
se CI and PCWP changes as measures for treatment
odulation in heart failure failed to show any significant
linical effect (28). We were also able to show that cardiac
ower measured at admission in patients with acute heart
ailure is strongly correlated with the rate of recurrent heart
ailure events during follow-up (29).
The results of the present study demonstrate that many
emodynamic variables including mean arterial pressure, CO,
ue to Predominant Left Ventricular Failure by Culprit Artery
flex Right Coronary
Artery Left Main Artery
p
Value
(37) 91.5  23.0 (77) 96.9  22.9 (16) 0.001
5) 16.4  6.0 (32) 22.5  11.0 (4) 0.028
0) 37.3  10.8 (48) 53.4  12.5 (5) 0.026
0) 22.8  6.2 (48) 31.7  11.7 (6) 0.056
3) 23.2  7.7 (66) 33.5  11.2 (11) 0.003
(24) 2.12  0.87 (49) 1.60  0.54 (7) 0.069
(24) 0.34  0.16 (43) 0.29  0.15 (6) 0.548
(21) 38.7  14.4 (33) 30.2  17.8 (5) 0.001
7] (10) 1,199 [679, 1,435] (19) 1,782 [1,782, 1,782] (1) 0.722
c balloon pump support. ( )  number of patients with available measurements; [ ] 
nary artery diastolic pressure; PAS  pulmonary artery systolic pressure; PCWP ock D
rcum
tery
24.2
5.8 (1
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atients with cardiogenic shock secondary to severe LV dys-
unction. In contrast with the findings in GUSTO-I, PCWP
as not a correlate of mortality in our study. On multivariate
nalysis, cardiac power and LV work were found to be the only
ndependent hemodynamic correlates of in-hospital mortality,
ith cardiac power being a stronger correlate than LV work.
ardiac power represents the rate of energy input the systemic
asculature receives from the heart at the level of the aortic
oot. This is the amount of energy available to maintain the
erfusion of the vital organs in shock. Left ventricular cardiac
ork, in contrast, is the amount of energy imparted only by the
V to the volume of blood ejected per minute. It does not
nclude the contribution of the left atrium to the maintenance
f the systemic circulation. Also, CPO was a better correlate
han CPI. Several studies have demonstrated an independent
ssociation between low body weight, short height, and in-
reased mortality after an acute MI (30–32). Therefore, the
djustment of CPO for body size yielding CPI may result in a
eaker association with mortality. Furthermore, body surface
rea may not be an adequate measure to correct for patient size
nd may skew the correlation of CPI with mortality. Of note,
n the GUSTO-I database, CO was a better predictor of
utcome than CI, although the authors suggest that this may
e related to the smaller number of patients with available CI
ata (10).
By receiver operator characteristic analysis, we were able
o determine that a CPO 0.53 W has a sensitivity and
pecificity of 0.66 to determine in-hospital mortality. The
ositive and negative predictive values for this CPO cutoff
ere 58% and 71%, respectively. These relatively low
redictive values—despite a strong association of CPO with
ortality—reflect the strength of analyzing CPO as a
ontinuous versus a categorical variable and demonstrate
hat there is not an important threshold effect. In a study
xamining the outcome of patients admitted due to acute
eart failure and monitored by right heart catheterization, a
imilar cutoff point was found to be useful for predicting the
ate of recurrent heart failure and death (G. Cotter, personal
ommunication, April 15, 2003). The correlation between
ow CPO and poor outcome was demonstrated previously
y Tan et al. (16), whose observed cutoff for increased
ortality (CPO 1 W) was, however, higher than the one
etermined in the present study. This discrepancy may be
xplained by the fact that in Tan’s study (16) the CPO
alues for predicting prognosis were obtained at doses of
harmacologic support yielding the individual maximal
PO, whereas in our study there was no prespecified
rotocol to record the CPO at maximal support. Further-
ore, Tan et al. (16) did not use receiver operator charac-
eristic analysis.
In addition to its prognostic significance, CPO can be
etermined without RHC. The measurement of CO by whole
ody electrical bioimpedance is accurate with the exception of
iseases of the aorta and aortic valve and significant peripheral idema. It may also avoid the potential overestimation of CO
y thermodilution in low CO states (14).
We found a significant decrease of CPI with increasing
ge. In normal aging hearts, there is a natural attrition of
bout 35% of cardiac myocytes throughout adult life.
espite a compensatory cellular hypertrophic response, this
oss of contractile cells leads to diminished cardiac function
ith decreased peak CPI and cardiac functional reserve
33,34). Furthermore, the capacity of the cardiovascular
ystem to react to a catecholamine-mediated response to
tress may be diminished with advancing age (35–37).
Female gender was associated with a lower CPI, inde-
endent of age. Whether this is a result of differential
atecholamine-mediated responsiveness or other mecha-
isms is unknown.
eft main culprit artery, three-vessel disease, and coro-
ary perfusion pressure. Patients with left main MI ap-
ear to have higher right-sided pressures and SVR and
ower CI and CPI than patients with other culprit arteries,
ut these differences did not reach statistical significance for
ost parameters, likely due to the small sample sizes.
Of note are the low median SVR values, despite vaso-
ressor use, with a very wide range for all culprit arteries
xcept for patients with left main MI. This might be related
o an inflammatory component in the pathogenesis of
ardiogenic shock (38).
In patients with left main MI, we found a lower coronary
erfusion pressure than for all other culprit arteries. Coro-
ary perfusion pressure was the only hemodynamic variable
hat was related to the number of diseased vessels. It was
ignificantly lower in patients with three-vessel disease
ompared with patients with either zero/one-, or two-vessel
isease. A decreased pressure gradient between the coronary
rterial system and the LV plays a central role in the
nitiation and progression of the downward spiral of hypo-
erfusion and worsening LV dysfunction in cardiogenic
hock (39). Below the lower limit of the autoregulatory
ange, coronary flow decreases markedly when the perfusion
ressure is decreased (40). Thus, the high mortality for
atients in cardiogenic shock with left main MI (78.6%) and
hree-vessel disease (50.8% vs. 39.8% vs. 35.0% for patients
ith two-vessel and zero/one-vessel disease, respectively, p
0.002) is not surprising (41).
tudy limitations. The majority of RHC measurements
73%) were obtained while the patients had no IABP support.
total of 27% of patients had their RHC measurement
ompleted in the time interval between IABP insertion and
emoval. Whether the IABP was on standby during the time
f RHC measurement is not known. Intra-aortic balloon
ump significantly increased mean arterial pressure and CI in
study of patients in cardiogenic shock (42). Therefore, IABP
se is expected to increase CPO. Most patients were on
upportive therapy with sympathomimetic amines (95%)
nd/or dobutamine (60%). These are likely to increase CPO,
ut the combination and intensity of various forms of support
n relation to RHC measurements was not assessed. Cardiac
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July 21, 2004:340–8 Cardiac Power in Cardiogenic Shockower output remained a significant correlate of mortality after
ontrolling for IABP use. It is unlikely that the predictive
ower of CPO was overestimated because of the supportive
reatment. In contrast, CPO might be a stronger correlate of
ortality in the absence of any support measures, because the
ifference in CPO between patients of various degrees of
ardiovascular compromise may be blunted by the supportive
herapy.
onclusions. Cardiac power is a novel hemodynamic mea-
ure. By incorporating both flow and pressure domains, it
epresents the cardiac pumping ability. In the present study,
ardiac power is the strongest hemodynamic correlate of
utcome for patients in cardiogenic shock. Increasing age
nd female gender are independently associated with lower
ardiac power.
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